<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p31" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_31{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_31{left:808px;bottom:1132px;letter-spacing:-0.08px;}
#t3_31{left:162px;bottom:1085px;letter-spacing:0.11px;word-spacing:1.78px;}
#t4_31{left:162px;bottom:1067px;letter-spacing:0.1px;word-spacing:-0.2px;}
#t5_31{left:162px;bottom:1050px;letter-spacing:0.11px;word-spacing:1.41px;}
#t6_31{left:162px;bottom:1032px;letter-spacing:0.09px;word-spacing:0.02px;}
#t7_31{left:141px;bottom:976px;letter-spacing:0.13px;word-spacing:0.01px;}
#t8_31{left:162px;bottom:941px;letter-spacing:0.12px;word-spacing:0.04px;}
#t9_31{left:162px;bottom:923px;letter-spacing:0.12px;word-spacing:0.03px;}
#ta_31{left:162px;bottom:888px;letter-spacing:0.1px;word-spacing:1.67px;}
#tb_31{left:162px;bottom:871px;letter-spacing:0.09px;word-spacing:-0.87px;}
#tc_31{left:162px;bottom:853px;letter-spacing:0.1px;word-spacing:0.94px;}
#td_31{left:162px;bottom:835px;letter-spacing:0.11px;word-spacing:0.51px;}
#te_31{left:162px;bottom:818px;letter-spacing:0.12px;word-spacing:3.54px;}
#tf_31{left:162px;bottom:800px;letter-spacing:0.11px;word-spacing:1.55px;}
#tg_31{left:162px;bottom:783px;letter-spacing:0.11px;word-spacing:2.45px;}
#th_31{left:162px;bottom:765px;letter-spacing:0.1px;word-spacing:1.51px;}
#ti_31{left:162px;bottom:748px;letter-spacing:0.12px;word-spacing:3.95px;}
#tj_31{left:162px;bottom:730px;letter-spacing:0.08px;word-spacing:0.54px;}
#tk_31{left:162px;bottom:712px;letter-spacing:0.1px;word-spacing:2.89px;}
#tl_31{left:771px;bottom:712px;letter-spacing:0.1px;word-spacing:2.87px;}
#tm_31{left:162px;bottom:695px;letter-spacing:0.12px;word-spacing:1.78px;}
#tn_31{left:162px;bottom:677px;letter-spacing:0.11px;word-spacing:0.09px;}
#to_31{left:733px;bottom:677px;letter-spacing:0.11px;}
#tp_31{left:162px;bottom:660px;letter-spacing:0.11px;word-spacing:2.6px;}
#tq_31{left:162px;bottom:642px;letter-spacing:0.11px;word-spacing:1.81px;}
#tr_31{left:392px;bottom:642px;letter-spacing:0.11px;word-spacing:1.8px;}
#ts_31{left:441px;bottom:642px;letter-spacing:0.08px;word-spacing:1.67px;}
#tt_31{left:162px;bottom:624px;letter-spacing:0.11px;word-spacing:-0.27px;}
#tu_31{left:162px;bottom:607px;letter-spacing:0.09px;}
#tv_31{left:141px;bottom:568px;letter-spacing:0.15px;word-spacing:2.13px;}
#tw_31{left:162px;bottom:547px;letter-spacing:0.14px;}
#tx_31{left:162px;bottom:512px;letter-spacing:0.15px;word-spacing:3.97px;}
#ty_31{left:333px;bottom:512px;letter-spacing:0.13px;word-spacing:3.95px;}
#tz_31{left:162px;bottom:495px;letter-spacing:0.11px;word-spacing:0.02px;}
#t10_31{left:162px;bottom:459px;letter-spacing:0.11px;word-spacing:0.52px;}
#t11_31{left:162px;bottom:442px;letter-spacing:0.11px;word-spacing:1.08px;}
#t12_31{left:162px;bottom:424px;letter-spacing:0.11px;word-spacing:0.02px;}
#t13_31{left:162px;bottom:407px;letter-spacing:0.12px;word-spacing:2.54px;}
#t14_31{left:162px;bottom:389px;letter-spacing:0.12px;word-spacing:1.87px;}
#t15_31{left:162px;bottom:371px;letter-spacing:0.11px;word-spacing:0.81px;}
#t16_31{left:162px;bottom:354px;letter-spacing:0.12px;word-spacing:2.93px;}
#t17_31{left:162px;bottom:336px;letter-spacing:0.1px;word-spacing:-0.07px;}
#t18_31{left:162px;bottom:319px;letter-spacing:0.11px;word-spacing:0.25px;}
#t19_31{left:162px;bottom:301px;letter-spacing:0.11px;word-spacing:2.48px;}
#t1a_31{left:162px;bottom:284px;letter-spacing:0.12px;word-spacing:1.76px;}
#t1b_31{left:162px;bottom:266px;letter-spacing:0.11px;word-spacing:1.63px;}
#t1c_31{left:162px;bottom:249px;letter-spacing:0.11px;word-spacing:0.2px;}
#t1d_31{left:162px;bottom:231px;letter-spacing:0.12px;word-spacing:3.42px;}
#t1e_31{left:162px;bottom:213px;letter-spacing:0.12px;word-spacing:4.76px;}
#t1f_31{left:162px;bottom:196px;letter-spacing:0.11px;word-spacing:0.02px;}
#t1g_31{left:162px;bottom:178px;letter-spacing:0.11px;word-spacing:-0.13px;}
#t1h_31{left:288px;bottom:178px;letter-spacing:0.11px;word-spacing:-0.13px;}
#t1i_31{left:162px;bottom:161px;letter-spacing:0.11px;word-spacing:0.02px;}
#t1j_31{left:162px;bottom:143px;letter-spacing:0.13px;}
#t1k_31{left:293px;bottom:143px;letter-spacing:0.12px;word-spacing:0.72px;}
#t1l_31{left:162px;bottom:126px;letter-spacing:0.11px;word-spacing:0.03px;}

.s0_31{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_31{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_31{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s3_31{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s4_31{font-size:15px;font-family:TimesNewRomanPS-ItalicMT_8n;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts31" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-ItalicMT_8n;
	src: url("fonts/TimesNewRomanPS-ItalicMT_8n.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg31Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg31" style="-webkit-user-select: none;"><object width="935" height="1210" data="31/31.svg" type="image/svg+xml" id="pdf31" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_31" class="t s0_31">Brain: Chemistry to Cognition </span><span id="t2_31" class="t s1_31">23 </span>
<span id="t3_31" class="t s0_31">the important role of autophagy in GSCs and the use of various autophagy modulators as combinational </span>
<span id="t4_31" class="t s0_31">agents to overcome chemoresistance in these GSCs. CSC is a relatively unexplored field with high potential, </span>
<span id="t5_31" class="t s0_31">and the present study is providing some important data that may form the basis for defining the mode of </span>
<span id="t6_31" class="t s0_31">therapy in the future. </span>
<span id="t7_31" class="t s2_31">S8.4. Neurotoxins therapeutics: Small molecule inhibitor a ray of hope </span>
<span id="t8_31" class="t s3_31">Nandita Saxena </span>
<span id="t9_31" class="t s0_31">Defence Research and Development Establishment, Jhansi Road, Gwalior (MP) </span>
<span id="ta_31" class="t s0_31">Neurotoxins are synthetic or naturally occurring substances that destroy, or impair the functioning of the </span>
<span id="tb_31" class="t s0_31">central and/or peripheral nervous system. Botulinum toxin is one of the neurotoxins (BoNTs) that target motor </span>
<span id="tc_31" class="t s0_31">neurons and block acetylcholine neurotransmitter release. This action results in the life-threatening flaccid </span>
<span id="td_31" class="t s0_31">paralysis that defines the disease botulism. Current therapeutic options are of a predominantly prophylactic </span>
<span id="te_31" class="t s0_31">nature and cannot be used in mass population, new strategies and ultimately potential treatments are </span>
<span id="tf_31" class="t s0_31">desperately needed to combat any widespread release of these neurotoxins. Small molecule, non-peptidic </span>
<span id="tg_31" class="t s0_31">inhibitors offer the best opportunity for the development of post-exposure therapeutics. Small molecule </span>
<span id="th_31" class="t s0_31">inhibitors, are potent, effective, safe, and possess suitable absorption, distribution, metabolism, excretion, </span>
<span id="ti_31" class="t s0_31">and toxicity (ADMET). Our laboratory is trying to identify the small molecule inhibitor against the </span>
<span id="tj_31" class="t s0_31">neurotoxin and other toxin which may cause neurotoxicity. Targeting catalytic domain of BONT is specific </span>
<span id="tk_31" class="t s0_31">approach and hold promise for selective therapy. Studies were performed to screen inhibitors </span><span id="tl_31" class="t s4_31">in silico </span>
<span id="tm_31" class="t s0_31">followed by high throughput screening via in house developed Fluorescence Based Thermal Shift Assay </span>
<span id="tn_31" class="t s0_31">(FTSA) and in vitro assays. Interaction of small molecules with toxin is confirmed via SPR. </span><span id="to_31" class="t s0_31">Endopeptidase </span>
<span id="tp_31" class="t s0_31">assay and cell free translation assay is also done to validate functionality of the molecules. Shortlisted </span>
<span id="tq_31" class="t s0_31">molecules were finally evaluated in </span><span id="tr_31" class="t s4_31">in vivo </span><span id="ts_31" class="t s0_31">to confirm their efficacy. Amide based derivative and quinol </span>
<span id="tt_31" class="t s0_31">molecules were found to be lead compound and may be considered for further development as post exposure </span>
<span id="tu_31" class="t s0_31">therapeutics. </span>
<span id="tv_31" class="t s2_31">S8.5. Restoration of nerve demyelination by methylcobalamin in an excitotoxic brain </span>
<span id="tw_31" class="t s2_31">disorder model </span>
<span id="tx_31" class="t s3_31">Surendra Kumar Trigun</span><span id="ty_31" class="t s0_31">, Anima Roy, Anamika, Debashmit Mallick, Archita Khanna Biochemistry </span>
<span id="tz_31" class="t s0_31">Section, Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi-221005 </span>
<span id="t10_31" class="t s0_31">Nerve demyelination is considered a common neuronal aberration of all neurodegenerative brain disorders. </span>
<span id="t11_31" class="t s0_31">Methylcobalamin (MeCobl) is a widely used supplement for the patients with neurological complications. </span>
<span id="t12_31" class="t s0_31">However, the mechanism by which MeCobl does so remains largely unexplored. We have studied the effect </span>
<span id="t13_31" class="t s0_31">of MeCobl on the neurochemical, neuroarchitectural and neurobehavioral aspects using moderate grade </span>
<span id="t14_31" class="t s0_31">hepatic encephalopathy (MoHE) model of neuroexcitotoxicity. The nurobehaviorily characterized MoHE </span>
<span id="t15_31" class="t s0_31">was induced in rats by administration of 100 mg/kg b.w of thioacetamide i.p. for 10 days. In experimental </span>
<span id="t16_31" class="t s0_31">group, MoHE rats were post treated with 500 mg/Kg. b.w. MeCobl, i.p.. Followed by neurochemical, </span>
<span id="t17_31" class="t s0_31">neuroarchitectural and neurobehavioral studies. In comparison to the control rats, a significant decline in the </span>
<span id="t18_31" class="t s0_31">level of the myelin basic protein (MBP) vs enhanced level of neurodegenerative changes could be observed </span>
<span id="t19_31" class="t s0_31">in the MoHE rats. This was consistent with the similar changes in the methyl group transfer enzymes, </span>
<span id="t1a_31" class="t s0_31">immunochemically detected deranged myelination of the hippocampus neurons and a compromise in the </span>
<span id="t1b_31" class="t s0_31">dendritic arborization and number of synaptic knobs in the CA1 pyramidal neurons of those MoHE rats. </span>
<span id="t1c_31" class="t s0_31">However, when these MoHE rats were treated with MeCobl, all these aberrations could be normalized back </span>
<span id="t1d_31" class="t s0_31">resulting into recovery in the neurobehavioral deficits observed with the MoHE pathogenesis. Taking </span>
<span id="t1e_31" class="t s0_31">together, it is evident that MeCobl treatment recovers MoHE associated neuronal derangements by </span>
<span id="t1f_31" class="t s0_31">modulating MeCobl utilizing neurochemistry vs re-myelination of the hippocampus neurons. </span>
<span id="t1g_31" class="t s3_31">Ethical Statement: </span><span id="t1h_31" class="t s0_31">The animal study was approved by the institutional animal ethical committee (IAEC) of </span>
<span id="t1i_31" class="t s0_31">Banaras Hindu University, for the care and use of Laboratory animals. </span>
<span id="t1j_31" class="t s3_31">Acknowledgement: </span><span id="t1k_31" class="t s0_31">This work was financially supported by the A DAE-BRNS project to SKT and award </span>
<span id="t1l_31" class="t s0_31">of CSIR SRF to AR. </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
